Tyra Biosciences’ $172.8 Million Initial Public Offering

Latham & Watkins represented Tyra Biosciences in the offering while Sidley advised the underwriters.Tyra Biosciences, Inc. has announced the pricing of its upsized initial public offering of 10,800,000…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now